Benjamin W Van Tassell, PharmD
Virginia Commonwealth University
4
4
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (4)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Antonio Abbate, MD, PhD
Virginia Commonwealth University
Shared therapeutic areas:
Worked with same sponsors:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
Jean-Olivier ARNAUD, Director
Assistance Publique HĂ´pitaux de Marseille
Shared therapeutic areas:
Suman Wason, MD
Lexicon Pharmaceuticals, Inc.
Shared therapeutic areas:
Alp Ikizler, MD
Vanderbilt University Medical Center
Shared therapeutic areas:
Melda Saglam, PhD
Hacettepe University
Shared therapeutic areas:
Naciye Vardar-Yagli, PhD
Hacettepe University
Shared therapeutic areas:
Shirley Wang, PhD, ScM
Brigham and Women's Hospital
Shared therapeutic areas:
John F Tisdale, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Shared therapeutic areas:
Worked with same sponsors:
Dong-Xin Wang, MD, PhD
Peking University First Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (4)
Showing 4 of 4 trials
Interleukin-1 Blockade for the Treatment of Heart Failure in Patients With Advanced Chronic Kidney Disease
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure
Interleukin (IL)-1 Blockade in Acute Heart Failure (Anakinra ADHF)
Interleukin-1 Blockade in Recently Decompensated Heart Failure
All 4 trials loaded